Haploid hematopoietic stem cell transplantation (HID-HSCT) is currently an effective treatment of malignant hematological and bone marrow failure diseases. This review focused upon recent explorations in the indications of HID-HSCT, optimization and improvement of transplant pretreatment schemes and research advances on preventive and therapeutic measures for common complications after transplantation. It was intended for clinician references.